Thomas W. Dubensky's most recent trade in Tempest Therapeutics Inc was a trade of 102,700 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 102,700 | 102,700 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 87,801 | 87,801 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Purchase of securities on an exchange or from another person at price $ 4.78 per share. | 07 Jan 2022 | 2,000 | 113,343 | - | 4.8 | 9,560 | Common Stock |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 53,100 | 53,100 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 111,343 | 111,343 | - | - | Common Stock | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 45,988 | 45,988 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 36,263 | 36,263 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Thomas W. Dubensky | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 8,050 | 8,050 | - | - | Stock Option (Right to Buy) |